Please ensure Javascript is enabled for purposes of website accessibility
Home / Information / Highlights

From Mechanisms to Tools: Research Solutions for Protein
2025-08-05 28

Apoptosis is a form of programmed cell death, specifically a regulated cell death process, characterized primarily by nuclear pyknosiscell shrinkagemembrane blebbing, and DNA fragmentation. Furthermore, caspase family proteases and other key apoptotic regulators play pivotal roles in apoptosis research. Three principal pathways mediate apoptosis: the intrinsic apoptotic pathway, the extrinsic apoptotic pathway, and the endoplasmic reticulum (ER) stress-induced apoptotic pathway.

The intrinsic pathway is activated by oligomerization of the B-cell lymphoma-2 (BCL-2) family proteins BAK and BAX. BAK/BAX oligomers form pores in the mitochondrial outer membrane, leading to the release of cytochrome c into the cytosol. Activation of BAK/BAX is regulated by proapoptotic (e.g., BAD and BID) or antiapoptotic (e.g., BCL-2) BCL-2 family proteins. Cytochrome c binds to Apaf-1, which recruits procaspase-9, forming the apoptosome. In the apoptosome, caspase-9 is activated by autoproteolytic cleavage, initiating the caspase-processing cascade.

The extrinsic pathway is activated by engagement of membrane receptors such as Tumor necrosis factor (TNF) receptor 1 (TNFR1), death receptors, or Toll-Like Receptors (TLRs). These proteins induce the formation of signaling complexes involving TNFR1-associated death domain protein (TRADD) or Fas-associated death domain protein (FADD), receptor-interacting serine/threonine protein kinase 1 (RIPK1) and procaspase-8. Ubiquitylation of RIPK1 by cellular inhibitors of apoptosis (cIAPs) stabilizes the complex and induces the activation of the transcription factor NFκB. FLIP, also present in the DISC, limits caspase-8 activity while promoting cell survival, cell proliferation, and the production of proinflammatory cytokines. Imbalances in this pathway, such as those imposed by cellular stress, allow the activation of caspase-8 and caspase-10, which in turn triggers the caspase activation cascade.

Once active, executioner caspases (i.e., caspase-2, -6, -8 and -10) bring about programmed apoptotic death. Apoptotic cells release messengers in the form of nucleosomal structures, shed receptors, anti-inflammatory metabolites or molecules packaged in apoptotic extracellular vesicles (ApoEVs). Phosphatidylserine (PS) molecules exposed on the outer surface of the plasma membrane function as “eat me” signals for phagocytes.

Fig 1. Apoptotic pathways and regulation(Cell Mol Immunol.2021 May;18(5):1106-1121.)

Endoplasmic Reticulum Stress-Induced Apoptotic Pathway: This represents a relatively novel regulatory mechanism for apoptosis. When cells undergo ER stress due to various factors, they initiate the unfolded protein response (UPR). The UPR is activated by three ER stress sensors: inositol-requiring enzyme 1 (IRE1)protein kinase R-like endoplasmic reticulum kinase (PERK), and activating transcription factor 6 (ATF6). IRE1 interacts with the adaptor protein TNF receptor-associated factor 2 (TRAF2), leading to activation of c-Jun N-terminal kinase (JNK). Activated JNK promotes the expression of the pro-apoptotic protein BCL-2-associated death promoter (BAD), thereby inducing apoptosis. Conversely, PERK facilitates the phosphorylation of eukaryotic translation initiation factor 2α (eIF2α) and enhances the translation of activating transcription factor 4 (ATF4). ATF4 upregulates the expression of the ER stress protein C/EBP homologous protein (CHOP). CHOP promotes apoptosis by increasing the expression of pro-apoptotic proteins BCL-2-associated X protein (BAX) and BCL-2 antagonist/killer (BAK).

Apoptosis is an indispensable physiological mechanism for tissue formation during embryogenesis. Indeed, the fine-tuned regulation of cell fate during embryonic development critically depends on mechanisms involving RIPK1 and caspase-8. Additionally, apoptosis serves as an essential tool for the immune system to combat infections and eliminate cells harboring irreparable DNA damage. Dysregulation of apoptosis occurs in numerous pathological conditions, including autoimmune disordersneurodegenerative diseases, and cancer, contributing to their pathogenesis. Consequently, understanding how apoptosis influences these biological processes may lead to therapeutic advances, ultimately benefiting human health.

Fig 2. Pro‐oncogenic effects of apoptotic cells(FEBS J.2021 Aug;288(15):4445-4463.)

Reference

1. Castillo Ferrer C, Berthenet K, Ichim G. Apoptosis – Fueling the oncogenic fire. The FEBS Journal. 2020;288(15):4445-4463.

2. Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of cell death. Cellular & Molecular Immunology. 2021;18(5):1106-1121.

 

AntibodySystem provides apoptosis-related proteins and antibodies, delivering more tools and solutions for apoptosis research.

Recombinant Protein

Catalog

Product Name

YHE35901

Recombinant Human CASP3/Caspase-3 Protein, N-His

YHG90201

Recombinant Human CASP8 Protein, N-His

YMG90201

Recombinant Mouse CASP8 Protein, N-His

YHF11001

Recombinant Human CASP9/Caspase 9 Protein, N-His-SUMO

YMG13201

Recombinant Mouse BAX Protein, N-His

YHG13201

Recombinant Human BAX Protein, N-His

YMG13202

Recombinant Mouse BAX Protein, N-His

YHC81001

Recombinant Human BCL2 Protein, C-His

YHA27801

Recombinant Human APAF1 Protein, N-His

YMJ41101

Recombinant Mouse NLRP3 Protein, N-His

YHH14501

Recombinant Human TRADD Protein, N-His

 

Antibody

Catalog

Product Name

RHE35909

Anti-CASP3/Caspase-3 Antibody (R3K78)

RHE35910

Anti-CASP3/Caspase-3 Antibody (R3K79)

RHE35901

Anti-Human CASP3/Caspase-3 Nanobody (SAA1223)

RHE35903

Anti-Human CASP3 Nanobody (VHH2)

RHG13210

Anti-BAX Antibody (R3R53)

RHG13211

Anti-BAX Antibody (R3R54)

RHG13212

Anti-BAX Antibody (R3R55)

RHG13202

Anti-Human BAX Nanobody (SAA1222)

RHG13201

Anti-Human BAX Antibody (6A7)

RHG13204

Anti-Human BAX Antibody (3C10)

RHC81001

Anti-Human BCL2 Nanobody (SAA1206)

RHC81005

Anti-BCL2 Antibody (R3C07)

RHA27801

Anti-APAF1 Antibody (R1B07)

RHA27803

Anti-APAF1 Antibody (R2T83)

RHD34001

Anti-Human CD120a/TNFRSF1A/TNFR1 Nanobody (SAA1242)

PHD34002

Anti-Human CD120a/TNFRSF1A/TNFR1 Polyclonal Antibody

RHD34003

Anti-CD120a/TNFRSF1A/TNFR1 Antibody (R3F34)

RHH14501

Anti-TRADD Antibody (R3T86)

PHH14501

Anti-TRADD Polyclonal Antibody

PHG42701

Anti-FADD Polyclonal Antibody

Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only